Compared to squamous NSCLC, non-squamous NSCLC is characterized by simpler mutations, which offers insight into why non-squamous NSCLC patients with PD-L1 expression ≥ 50% can benefit from various ICI treatment regimens[37]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.